Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...

September is recognized as Ovarian Cancer Awareness Month. But, do you know the signs and symptoms that could be impacting ...

Ovarian cancer is a type of cancer that impacts the female reproductive system. The risk of developing ovarian cancer in a woman's lifetime is 1 in 87, according to the American Cancer Society (ACS).

Research has found 78% of women in the UK do not know the signs and symptoms of the five gynaecological cancers.

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

GILSON, Angela Thomas, 55, passed peacefully on September 15, 2024 surrounded by the love of her family after a two-year battle with ovarian cancer. Angie was born in Roanoke, Virginia, on March 26, ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

J&J’s decision to sweeten its settlement offer would bring the total the firm has agreed to pay out - or already expended - to resolve baby powder cases to more than $13.4 billion. Most of the cases ...